Claiming to de-extinct the dire wolf, Colasant Biosciences has drawn criticism from numerous specialists who contend the corporation is misrepresenting the public. Critics point out that Colossal is actually constructing a genetically modified animal looking like the dire wolf, not resurrecting the original, even while she implies they are replicating the ancient species. Ethical issues have been generated by this since one wonders about the consequences for ecology and animal welfare. The argument has also spurred a more general discussion on the ethics and viability of de-extinction as well as the need of open communication in scientific activities.
Tag: Colossal Biosciences woolly mammoth
Colossal Biosciences Plan to Bring Back Dinosaurs Using Modern Science & Gene-Editing Advances
Colossal Biosciences has led the pack of de-extinction companies and just received a record-breaking $200 million in Series C funding from TWG Global for its high-profile projects. From initially reviving the woolly mammoth, dodo, and thylacine, they have shifted their gears to the most ambitious dream: bringing back dinosaurs into the world. Colossal will change the course of evolutionary history. With cutting-edge tools such as CRISPR-Cas9 and artificial womb technologies, not to mention synthetic biology tools, it appears to rewrite everything that had passed and was previously thought to remain so. There is a greater meaning behind species revival; Colossal can help researchers in the issues of human health, agriculture, and biodiversity preservation, aside from saving the dinosaurs, which are at present still strictly theoretical.